The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling

Nature Immunology

Volumn 14, Issue 6, 2013, Pages 593-602

  Gracias, Donald T ^a   Stelekati, Erietta ^a   Hope, Jennifer L ^a   Boesteanu, Alina C ^a   Doering, Travis A ^b   Norton, Jillian ^a   Mueller, Yvonne M ^a   Fraietta, Joseph A ^a   Wherry, E John ^b   Turner, Martin ^c   Katsikis, Peter D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1BETA; MICRORNA 155; STAT1 PROTEIN; TUMOR NECROSIS FACTOR;

ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; EFFECTOR CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; MEMORY CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; VIRAL CLEARANCE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; IMMUNOBLOTTING; IMMUNOLOGIC MEMORY; INTERFERON REGULATORY FACTOR-7; INTERFERONS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84878259075     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2576     Document Type: Article

References (54)

1. Lodish, H.F., Zhou, B., Liu, G. & Chen, C.Z. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 8, 120-130 (2008).
2. Lewis, B.P., Burge, C.B. & Bartel, D.P. Conserved seed pairing, often fanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
3. Miranda, K.C. et al. A pattern-based method for the identifcation of microRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217 (2006).
4. Friedman, R.C., Farh, K.K., Burge, C.B. & Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105 (2009).
5. Lee, Y., Jeon, K., Lee, J.T., Kim, S. & Kim, V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663-4670 (2002).
6. Liu, J. et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437-1441 (2004).
7. Lund, E., Guttinger, S., Calado, A., Dahlberg, J.E. & Kutay, U. Nuclear export of microRNA precursors. Science 303, 95-98 (2004).
8. Muljo, S.A. et al. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202, 261-269 (2005).
9. Zhang, N. & Bevan, M.J. Dicer controls CD8+ T-cell activation, migration, and survival. Proc. Natl. Acad. Sci. USA 107, 21629-21634 (2010).
10. Clurman, B.E. & Hayward, W.S. Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specifc events. Mol. Cell Biol. 9, 2657-2664 (1989).
11. Rodriguez, A. et al. Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611 (2007).
12. Vigorito, E. et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27, 847-859 (2007).
13. Thai, T.H. et al. Regulation of the germinal center response by microRNA-155. Science 316, 604-608 (2007).
14. Costinean, S. et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103, 7024-7029 (2006).
15. Tili, E. et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-a stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179, 5082-5089 (2007).
16. O'Connell, R.M. et al. MicroRNA-155 promotes autoimmune infammation by enhancing infammatory T cell development. Immunity 33, 607-619 (2010).
17. Kohlhaas, S. et al. Cutting edge: The Foxp3 target miR-155 contributes to the development of regulatory T cells. J. Immunol. 182, 2578-2582 (2009).
18. Lu, L.F. et al. Foxp3-dependent microRNA155 confers competitive ftness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80-91 (2009).
19. Tsai, C.Y., Allie, S.R., Zhang, W. & Usherwood, E.J. MicroRNA miR-155 affects antiviral effector and effector memory CD8 T cell differentiation. J. Virol. 87, 2348-2351 (2013).
20. + T cell responses to acute viral and intracellular bacterial challenges. J. Immunol. 190, 1210-1216 (2013).
21. Kolumam, G.A., Thomas, S., Thompson, L.J., Sprent, J. & Murali-Krishna, K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202, 637-650 (2005).
22. Curtsinger, J.M. et al. IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174, 4465-4469 (2005).
23. Gil, M.P., Salomon, R., Louten, J. & Biron, C.A. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 107, 987-993 (2006).
24. Marshall, H.D., Urban, S.L. & Welsh, R.M. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J. Virol. 85, 5929-5939 (2011).
25. McNally, J.M. et al. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75, 5965-5976 (2001).
26. Ebert, P.J., Jiang, S., Xie, J., Li, Q.J. & Davis, M.M. An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat. Immunol. 10, 1162-1169 (2009).
27. Li, Q.J. et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129, 147-161 (2007).
28. Trotta, R. et al. miR-155 regulates IFN-y production in natural killer cells. Blood 119, 3478-3485 (2012).
29. Agarwal, P. et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J. Immunol. 183, 1695-1704 (2009).
30. Sana, T.R., Janatpour, M.J., Sathe, M., McEvoy, L.M. & McClanahan, T.K. Microarray analysis of primary endothelial cells challenged with different infammatory and immune cytokines. Cytokine 29, 256-269 (2005).
31. Tsuchihashi, S., Zhai, Y., Fondevila, C, Busuttil, R.W. & Kupiec-Weglinski, J.W. HO-1 upregulation suppresses type 1 IFN pathway in hepatic ischemia/reperfusion injury. Transplant. Proc. 37, 1677-1678 (2005).
32. Kashiwada, M. et al. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4+CD25+ T cell development. J. Immunol. 176, 3958-3965 (2006).
33. O'Connell, R.M., Chaudhuri, A.A., Rao, D.S. & Baltimore, D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 106, 7113-7118 (2009).
34. Cocolakis, E. et al. Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. J. Biol. Chem. 283, 1293-1307 (2008).
35. Erickson, S. et al. Interferon-α inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes. Eur. J. Biochem. 269, 29-37 (2002).
36. Haasch, D. et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol. 217, 78-86 (2002).
37. Dondi, E., Rogge, L., Lutfalla, G., Uze, G. & Pellegrini, S. Down-modulation of responses to type I IFN upon T cell activation. J. Immunol. 170, 749-756 (2003).
38. Erickson, S. et al. Interferon-α inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins. Cell Growth Differ. 10, 575-582 (1999).
39. Gimeno, R., Lee, C.K., Schindler, C. & Levy, D.E. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by α/β interferon in T lymphocytes. Mol. Cell Biol. 25, 5456-5465 (2005).
40. Tanabe, Y. et al. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-αβ responses in T lymphocytes. J. Immunol. 174, 609-613 (2005).
41. Linsley, P.S. et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell Biol. 27, 2240-2252 (2007).
42. Tsang, J., Zhu, J. & van Oudenaarden, A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol. Cell 26, 753-767 (2007).
43. Wherry, E.J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225-234 (2003).
44. Usherwood, E.J. et al. Immunological control of murine gammaherpesvirus infection is independent of perforin. J. Gen. Virol. 78, 2025-2030 (1997).
45. + T cells require CD28 costimulation. J. Immunol. 179, 6494-6503 (2007).
46. + T cell responses during the effector phase in vivo. J. Immunol. 186, 4599-4608 (2011).
47. Shen, L., Evel-Kabler, K., Strube, R. & Chen, S.Y. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specifc anti-tumor immunity. Nat. Biotechnol. 22, 1546-1553 (2004).
48. Abate, A., Zhao, H., Wong, R.J. & Stevenson, D.K. The role of Bach1 in the induction of heme oxygenase by tin mesoporphyrin. Biochem. Biophys. Res. Commun. 354, 757-763 (2007).
49. Lu, Y. et al. Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic. J. Biol. Chem. 281, 36683-36690 (2006).
50. Lin, R., Mamane, Y. & Hiscott, J. Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 275, 34320-34327 (2000).
51. Irizarry, R.A. et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003).
52. Tusher, V.G., Tibshirani, R. & Chu, G. Signifcance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001).
53. Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500-501 (2006).
54. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).